Clinical Scorecard: Influence of Sarcopenia on Ventricular Remodeling Post-Coronary Artery Bypass Grafting in Aged Individuals with Coronary Heart Disease
At a Glance
Category
Detail
Condition
Ventricular remodeling after coronary artery bypass grafting (CABG) in elderly patients with coronary heart disease (CHD)
Key Mechanisms
Sarcopenia contributes to ventricular remodeling via impaired muscle strength, metabolic dysregulation, inflammation, oxidative stress, autophagy, apoptosis, and neurohormonal pathways
Target Population
Elderly patients (≥60 years) with CHD undergoing CABG
Care Setting
Hospital setting with postoperative follow-up after CABG
Key Highlights
Incidence of ventricular remodeling post-CABG in elderly CHD patients was 23.7%.
Sarcopenia independently increased risk of ventricular remodeling (OR=2.230) with high sensitivity (90%) and moderate specificity (47%).
Other independent risk factors include smoking, diabetes, severe coronary stenosis, elevated Lp(a), uric acid, PAR2, and monocyte-to-HDL ratio.
Guideline-Based Recommendations
Diagnosis
Assess sarcopenia status preoperatively in elderly CHD patients scheduled for CABG.
Evaluate inflammatory and metabolic markers such as PAR2 and monocyte-to-HDL ratio to aid risk stratification.
Management
Implement strategies to address sarcopenia pre- and post-CABG to potentially reduce ventricular remodeling risk.
Optimize control of modifiable risk factors including smoking cessation and diabetes management.
Monitoring & Follow-up
Monitor left ventricular end-diastolic volume changes post-CABG to detect ventricular remodeling (ΔLVEDV ≥ 15%).
Regularly assess muscle strength and function as part of postoperative rehabilitation.
Risks
Sarcopenia significantly increases risk of adverse ventricular remodeling after CABG.
Elevated inflammatory and metabolic markers contribute to remodeling risk and poorer prognosis.
Patient & Prescribing Data
Elderly patients with CHD undergoing CABG
Recognition of sarcopenia as a risk factor supports integration of muscle-strengthening and metabolic interventions alongside standard postoperative care to improve outcomes.
Clinical Best Practices
Screen elderly CHD patients for sarcopenia prior to CABG to identify high-risk individuals.
Incorporate inflammatory and metabolic biomarker assessment (PAR2, MHR, Lp(a), UA) into preoperative evaluation.
Address modifiable risk factors such as smoking and diabetes aggressively before and after surgery.
Use echocardiographic monitoring of LVEDV changes to detect early ventricular remodeling.
Develop multidisciplinary rehabilitation programs targeting muscle preservation and metabolic health post-CABG.
